研究领域

Chemical Sciences Biomolecular Modelling and Design

Modelling Biophysical Phenomena -Protein stability and dynamics Glycobiology Protein-small molecule, protein-protein and protein-carbohydrate interactions Ribosomes and antibacterial molecules Structure based drug design

近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Arooj, M., N. S. Gandhi, C. Kreck, D. W. Arrigan, and R. L. Mancera. 2016.“Adsorption and Unfolding of Lysozyme at a Polarized Aqueous-Organic Liquid Interface.”Journal of Physical Chemistry B 120 (12): 3100-3112. Gandhi, N. S., I. Landrieu, C. Byrne, P. Kukic, L. Amniai, F. Cantrelle, J. Wieruszeski, R. L. Mancera, Y. Jacquot, and G. Lippens. 2015.“A Phosphorylation-Induced Turn Defines the Alzheimer’s Disease AT8 Antibody Epitope on the Tau Protein.”Angewandte Chemie - International Edition 54 (23): 6819-6823. Gandhi, N. S., and R. L. Mancera. 2012. “Developing drugs from sugars: current state of glycosaminoglycan-derived therapeutics.” In Structural Glycobiology, ed. Elizabeth Yuriev and Paul A Ramsland, 259-294. USA: CRC Press. Gandhi, N. S., and R. L. Mancera. 2012.“Prediction of heparin binding sites in bone morphogenetic proteins (BMPs).”Biochimica et Biophysica Acta - Proteins and Proteomics 1824: 1374-1381. Zuo, Z., N. S. Gandhi, K. M. arndt, and R. L. Mancera. 2012.“Free Energy Calculations of the Interactions of c-Jun-based Synthetic Peptides with the c-Fos Protein.”Biopolymers 97 (11): 899-909. Gandhi, N. S., C. Freeman, C. R. Parish, and R. L. Mancera. 2012.“Computational analyses of the catalytic and heparin binding sites and their interactions with glycosaminoglycans in glycoside hydrolase family 79 endo-beta-D-glucuronidase (heparanase).”Glycobiology 22: 35-55. Tajne, S., R. Sanam, R. Gundla, N. S. Gandhi, R. L. Mancera, D. Boddupally, D. R. Vudem, and V. R. Khareedu. 2012.“Molecular modeling of Bt Cry1Ac (DI-DII)-ASAL (Allium sativum lectin)-fusion protein and its interaction with aminopeptidase N (APN) receptor of Manduca sexta.”Journal of Molecular Graphics and Modeling 33: 61-76. Raval, S., P. Raval, D. Bandyopadhyay, K. Soni, D. Yevale, D. Jogiya, H. Modi, A. Joharapurkar, N. S. Gandhi, M. Jain et al. 2008.“Design and synthesis of novel 3-hydroxy-cyclobut-3-ene-1,2-dione derivatives as thyroid hormone receptor ß (TR-ß) selective ligands.”Bioorganic & Medicinal Chemistry Letters 18 (14): 3919-3924. Kumar Srivastava, B., R. Soni, J. Patel, S. Jha, S. Shedage, N. S. Gandhi, K. Sairam, V. Pawar, N. Sadhwani, P. Mitra et al. 2008.“Facile synthesis, ex-vivo and in vitro screening of 3-sulfonamide derivative of 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxy lic acid piperidin-1-ylamide (SR141716) a potent CB1 receptor antagonist.”Bioorganic & Medicinal Chemistry Letters 18 (14): 3882-3886. Srivastava, B., A. Joharapurkar, S. Raval, J. Patel, R. Soni, P. Raval, A. Gite, A. Goswami, N. Sadhwani, N. S. Gandhi et al. 2007.“Diaryl dihydropyrazole-3-carboxamides with significant in vivo antiobesity activity related to CB1 receptor antagonism: Synthesis, biological evaluation, and molecular modeling in the homology model.”Journal of Medicinal Chemistry 50 (24): 5951-5966. Lohray, B., N. S. Gandhi, B. Srivastava, and V. Lohray. 2006.“3D QSAR studies of N-4-arylacryloylpiperazin-1-yl-phenyl-oxazolidinones: A novel class of antibacterial agents.”Bioorganic & Medicinal Chemistry Letters 16 (14): 3817-3823.